Paradigm Financial Partners, LLC Amgen Inc Transaction History

Paradigm Financial Partners, LLC

$708 Million
Q3 2024

A detailed history of Paradigm Financial Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 15,021 shares of AMGN stock, worth $3.97 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

15,021

Previous 16,634 9.7%

Holding current value

$3.97 Million

Previous $5.2 Million 6.89%

% of portfolio

0.68%

Previous 0.79%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $499,029 - $544,193	-1,613 Reduced 9.7%	15,021 $4.84 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $222,023 - $269,816	845 Added 5.35%	16,634 $5.2 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $525,640 - $634,514	1,955 Added 14.13%	15,789 $4.49 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $703,175 - $793,265	2,750 Added 24.81%	13,834 $3.98 Million
Q3 2023 Oct 12, 2023	BUY	$218.65 - $271.46 $2.22 Million - $2.76 Million	10,166 Added 1107.41%	11,084 $2.98 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $8,356 - $9,881	-39 Reduced 4.08%	918 $203,000
Q1 2023 Apr 11, 2023	SELL	$225.79 - $275.2 $4,967 - $6,054	-22 Reduced 2.25%	957 $231,000
Q4 2022 Jan 27, 2023	SELL	$229.03 - $291.01 $3,664 - $4,656	-16 Reduced 1.61%	979 $0
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $6,509 - $7,341	-29 Reduced 2.83%	995 $230,000
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $5,306 - $5,905	-23 Reduced 2.2%	1,024 $253,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $13,375 - $14,796	61 Added 6.19%	1,047 $262,000
Q4 2021 Feb 18, 2022	SELL	$198.88 - $227.6 $425,006 - $486,381	-2,137 Reduced 68.43%	986 $222,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $402,930 - $461,117	2,026 Added 184.69%	3,123 $702,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $6,580 - $7,709	-31 Reduced 2.75%	1,097 $229,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $700 - $777	-3 Reduced 0.27%	1,128 $275,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $6,213 - $7,240	-28 Reduced 2.42%	1,131 $281,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $7,356 - $8,760	-34 Reduced 2.85%	1,159 $271,000
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $12,201 - $13,569	-52 Reduced 4.18%	1,193 $303,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $67,255 - $82,531	-340 Reduced 21.45%	1,245 $319,000
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $42,826 - $56,799	235 Added 17.41%	1,585 $347,000
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $567 - $729	3 Added 0.22%	1,350 $325,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $2,785 - $3,337	16 Added 1.2%	1,347 $265,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $10,490 - $11,825	-58 Reduced 4.18%	1,331 $253,000
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $247,797 - $289,259	1,389 New	1,389 $270,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.

Account

Paradigm Financial Partners, LLC Amgen Inc Transaction History